Roche Launches First Advanced Gastric Cancer Med In China
This article was originally published in PharmAsia News
Executive Summary
On Oct. 13, Roche Holding AG launched Herceptin in China, an HER2-positive advanced gastric cancer drug shown to reduce risk of death by 35% and extend patients’ lives by over one year in Phase III clinical trials.